West Pharmaceutical Services (WST) Current Assets (2009 - 2026)

West Pharmaceutical Services has disclosed Current Assets across 18 years of filings, most recently posting $1.8 billion for Q2 2026.

• In Q2 2026, Current Assets rose 7.53% year-over-year to $1.8 billion; the TTM figure through Jun 2026 stood at $1.8 billion (up 7.53% YoY), while the FY2025 annual figure was $2.0 billion, up 28.61% from the prior year.
• Current Assets came in at $1.8 billion for Q2 2026 at West Pharmaceutical Services, down from $1.8 billion in the prior quarter.
• In the past five years, Current Assets ranged from a high of $2.0 billion in Q4 2025 to a low of $1.5 billion in Q1 2025.
• Average Current Assets over 5 years is $1.8 billion, with a median of $1.8 billion recorded in 2022.
• Year-over-year, Current Assets dropped 21.38% in 2024 and advanced 28.61% in 2025.
• Over 5 years, Current Assets stood at $1.9 billion in 2022, then gained by 0.88% to $1.9 billion in 2023, then declined by 20.57% to $1.5 billion in 2024, then increased by 28.61% to $2.0 billion in 2025, then decreased by 8.63% to $1.8 billion in 2026.
• Per Business Quant data, the three most recent Current Assets figures were $1.8 billion in Q2 2026, $1.8 billion in Q1 2026, and $2.0 billion in Q4 2025.